BioSpectrum India Magazine
BioSpectrum India Magazine

BioSpectrum India Magazine

This is an e-magazine. Download App & Read offline on any device.

Preview

Indian Pharma spending Rs 200 Bn on R&D

Indian pharma companies are gearing up to take on their global peers in terms of expenditure on research and development (R&D), which has shown a steady increase in the last few years. Over the years Indian pharma industry has been often pulled up for spending too little on R&D. But the latest trend shows that India’s biggest pharmaceutical companies are now investing more in this direction. Besides building on the traditional generic product pipeline, pharma companies are now investing in research on complex generics, specialty and differentiated products, and biosimilars. For the FY2018, the R&D expenses have constituted 9.1 per cent of the cumulative revenues of the companies. The cumulative R&D spend for the top 10 pharma companies has been around Rs 95 billion or Rs 9500 crores this fiscal. This figure eventually reaches a score of Rs 20,000 crores after considering the cumulative expenditure by other small and medium players of the Indian pharma industry working equally hard in the field of R&D.

The BioSpectrum India edition was launched in March 2003 and is India's first comprehensive biotech business monthly magazine. It provides comprehensive coverage of the exciting happenings in life sciences, which include BioPharma, BioAgriculture, BioInformatics, BioIndustrial, BioSuppliers and BioServices and show cases the emerging Indian entrepreneurships in biotech industry. In a short time BioSpectrum has emerged as the most preferred platform to engage the life sciences industry in India and Asia Pacific. It is also widely accepted by research and academia community. Top key policy makers in the Central and state government use the magazine as a platform to reach out the Indian Biotech Industry. BioSpectrum has columns by Indian's top policy makers, biotechnology professionals, scientists and NGOs. Readers of BioSpectrum are from among the key Policy Makers, Key Executives and the Influencer's in Biotechnology, Pharmaceutical Companies, Research Heads of Clinical Research, Clinical Trials and Contract Mfg Organizations, Educational Institutes, Consultants, Fund Managers etc

Previous Issues